MediWound MDWD Stock
MediWound Price Chart
MediWound MDWD Financial and Trading Overview
| MediWound stock price | 13.73 USD |
| Previous Close | 14.33 USD |
| Open | 14.26 USD |
| Bid | 10.26 USD x 200 |
| Ask | 17.61 USD x 200 |
| Day's Range | 13.62 - 14.52 USD |
| 52 Week Range | 13.62 - 22.51 USD |
| Volume | 177.75K USD |
| Avg. Volume | 89.36K USD |
| Market Cap | 177.62M USD |
| Beta (5Y Monthly) | 0.218 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.26 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.17 USD |
MDWD Valuation Measures
| Enterprise Value | 141.4M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.225225 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.267295 |
| Price/Book (mrq) | 4.294593 |
| Enterprise Value/Revenue | 9.766 |
| Enterprise Value/EBITDA | -5.234 |
Trading Information
MediWound Stock Price History
| Beta (5Y Monthly) | 0.218 |
| 52-Week Change | -35.56% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 22.51 USD |
| 52 Week Low | 13.62 USD |
| 50-Day Moving Average | 16.63 USD |
| 200-Day Moving Average | 17.54 USD |
MDWD Share Statistics
| Avg. Volume (3 month) | 89.36K USD |
| Avg. Daily Volume (10-Days) | 117.91K USD |
| Shares Outstanding | 12.85M |
| Float | 8.91M |
| Short Ratio | 24.19 |
| % Held by Insiders | 15.85% |
| % Held by Institutions | 58.24% |
| Shares Short | 1.51M |
| Short % of Float | 13.46% |
| Short % of Shares Outstanding | 11.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -180.29% |
| Operating Margin (ttm) | -541.016% |
| Gross Margin | 19.60% |
| EBITDA Margin | -186.58% |
Management Effectiveness
| Return on Assets (ttm) | -23.50% |
| Return on Equity (ttm) | -71.82% |
Income Statement
| Revenue (ttm) | 14.48M USD |
| Revenue Per Share (ttm) | 1.22 USD |
| Quarterly Revenue Growth (yoy) | -62.70% |
| Gross Profit (ttm) | 2.84M USD |
| EBITDA | -27015000 USD |
| Net Income Avi to Common (ttm) | -26105000 USD |
| Diluted EPS (ttm) | -2.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.65M USD |
| Total Cash Per Share (mrq) | 3.47 USD |
| Total Debt (mrq) | 8.13M USD |
| Total Debt/Equity (mrq) | 19.62 USD |
| Current Ratio (mrq) | 2.41 |
| Book Value Per Share (mrq) | 3.218 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18765000 USD |
| Levered Free Cash Flow (ttm) | -18442750 USD |
Profile of MediWound
| Country | United States |
| State | N/A |
| City | Yavne |
| Address | 42 Hayarkon Street |
| ZIP | 8122745 |
| Phone | 972 7 797 14100 |
| Website | https://www.mediwound.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 121 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Q&A For MediWound Stock
What is a current MDWD stock price?
MediWound MDWD stock price today per share is 13.73 USD.
How to purchase MediWound stock?
You can buy MDWD shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MediWound?
The stock symbol or ticker of MediWound is MDWD.
Which industry does the MediWound company belong to?
The MediWound industry is Biotechnology.
How many shares does MediWound have in circulation?
The max supply of MediWound shares is 12.85M.
What is MediWound Price to Earnings Ratio (PE Ratio)?
MediWound PE Ratio is now.
What was MediWound earnings per share over the trailing 12 months (TTM)?
MediWound EPS is -2.26 USD over the trailing 12 months.
Which sector does the MediWound company belong to?
The MediWound sector is Healthcare.
MediWound MDWD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Composite Total Return XCMP | 33104.2 USD — |
-0.89
|
— — | 32999.64 USD — | 33445.55 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}